Display options
Cite
Davis J, Chun AK, Borum ML. Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. World J Hepatol. 2016;8(19):790-5doi: 10.4254/wjh.v8.i19.790.
Davis, J., Chun, A. K., & Borum, M. L. (2016). Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. World journal of hepatology, 8(19), 790-5. https://doi.org/10.4254/wjh.v8.i19.790
Davis, Jessica, et al. "Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt." World journal of hepatology vol. 8,19 (2016): 790-5. doi: https://doi.org/10.4254/wjh.v8.i19.790
Davis J, Chun AK, Borum ML. Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. World J Hepatol. 2016 Jul 08;8(19):790-5. doi: 10.4254/wjh.v8.i19.790. PMID: 27429715; PMCID: PMC4937167.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2016 Jul 08;8(19):790-5. doi: 10.4254/wjh.v8.i19.790.

Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt.

World journal of hepatology

Jessica Davis, Albert K Chun, Marie L Borum

Affiliations

  1. Jessica Davis, Department of Internal Medicine, George Washington University, Washington, DC 20037, United States.

PMID: 27429715 PMCID: PMC4937167 DOI: 10.4254/wjh.v8.i19.790

Abstract

Cirrhotic patients with recurrent variceal bleeds who have failed prior medical and endoscopic therapies and are not transjugular intrahepatic portosystemic shunt candidates face a grim prognosis with limited options. We propose that mesocaval shunting be offered to this group of patients as it has the potential to decrease portal pressures and thus decrease the risk of recurrent variceal bleeding. Mesocaval shunts are stent grafts placed by interventional radiologists between the mesenteric system, most often the superior mesenteric vein, and the inferior vena cava. This allows flow to bypass the congested hepatic system, reducing portal pressures. This technique avoids the general anesthesia and morbidity associated with surgical shunt placement and has been successful in several case reports. In this paper we review the technique, candidate selection, potential pitfalls and benefits of mesocaval shunt placement.

Keywords: Esophageal and gastric varices; Gastrointestinal hemorrhage; Portal hypertension; Surgical portacaval shunt; Transjugular intrahepatic portasystemic shunt

References

  1. Hepatology. 1994 Jul;20(1 Pt 1):46-55 - PubMed
  2. J Vasc Interv Radiol. 2012 Apr;23 (4):565-7 - PubMed
  3. Dig Dis Sci. 1996 Mar;41(3):578-84 - PubMed
  4. Ann Intern Med. 1995 Aug 15;123(4):280-7 - PubMed
  5. J Vasc Interv Radiol. 2012 Jan;23 (1):136-41 - PubMed
  6. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD000553 - PubMed
  7. Clin Gastroenterol Hepatol. 2015 Nov;13(12 ):2109-17 - PubMed
  8. J Clin Gastroenterol. 2009 Nov-Dec;43(10):982-4 - PubMed
  9. Cardiovasc Intervent Radiol. 2015 Oct;38(5):1316-9 - PubMed
  10. Am J Transplant. 2016 Jan;16 Suppl 2:69-98 - PubMed
  11. N Engl J Med. 1994 Jan 20;330(3):165-71 - PubMed
  12. Ann Surg. 1987 Jul;206(1):48-52 - PubMed
  13. JAMA Surg. 2014 Feb;149(2):155-69 - PubMed
  14. Hepatol Res. 2015 Dec;45(13):1307-11 - PubMed
  15. Liver Int. 2012 Oct;32(9):1407-14 - PubMed
  16. J Vasc Interv Radiol. 1996 Sep-Oct;7(5):769-73 - PubMed
  17. Transplantation. 2000 May 15;69(9):1772-4 - PubMed
  18. Lancet. 1990 Jul 21;336(8708):153-6 - PubMed
  19. Liver Transpl. 2015 Aug;21(8):1016-21 - PubMed

Publication Types